64307 Switching between Janus kinase inhibitors for treatment of alopecia areata - 02/09/25
Doi : 10.1016/j.jaad.2025.05.344
Aubrey Martin, BS
Department of Dermatology, Lahey Hospital & Medical Center, Burlington, Massachusetts, United States
Divya Sharma, MD
Department of Dermatology, Lahey Hospital & Medical Center, Burlington, Massachusetts, United States
Mack Su, MD, PhD
Department of Dermatology, Lahey Hospital & Medical Center, Burlington, Massachusetts, United States
Kristen Kelley, BA
Department of Dermatology, Lahey Hospital & Medical Center, Burlington, Massachusetts, United States
Maryanne Senna, MD
Department of Dermatology, Lahey Hospital & Medical Center, Burlington, Massachusetts, United States
Department of Dermatology, Harvard Medical School, Boston, Massachusetts, United States
Il testo completo di questo articolo è disponibile in PDF.
| Commercial Disclosure: NA. |
© 2025
Pubblicato da Elsevier Masson SAS.
Vol 93 - N° 3S
P. AB85 - settembre 2025 Ritorno al numero
Articolo precedente
- 63519 Sustained Disease Control Among Adults with Moderate-to-Severe Atopic Dermatitis in Clinical Practice: 5-Year Follow-up Results From the RELIEVE-AD Study
- Zhixiao Wang, Bruno Martins, Jingdong Chao, Min Yang, Kerry Noonan, Brad Shumel, Debra Sierka, Alexa Kimball
- 64015 Systematic Review and Meta-Analysis of Emollient Use for the Prevention of Atopic Dermatitis in Children
- Luísa Menegaz Veronese, Gabriela Oliveira Caetano, Maria Eduarda Cavalcanti Souza, Jade Lingiardi Altoé, Isabella Christina Amaral de Lara, Laíse Lênin Leodoro Silva, Maria Eduarda Silva, Artur Menegaz de Almeida, Michele Kreuz
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?